Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2013-12-19

FDA Approved: OMEPRAZOLE — Supplemental Application (Sandoz Inc)

View source ↗

Summary

The FDA approved a supplemental application for omeprazole from Sandoz Inc, authorizing updates to the approved generic product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Omeprazole (Omeprazole)

Snippet

SUPPL AP for OMEPRAZOLE (OMEPRAZOLE)